Mesopram
Alternative Names: SH 636; ZK 117137Latest Information Update: 19 Aug 2005
At a glance
- Originator Bayer Schering Pharma
- Class Anti-inflammatories
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Multiple sclerosis
Most Recent Events
- 01 Jan 2005 Discontinued - Phase-II for Multiple sclerosis in USA (PO)
- 01 Jan 2005 Discontinued - Preclinical for Inflammation in Germany (unspecified route)
- 16 Jul 2003 Preclinical trials in Inflammation in Germany (unspecified route)